Suggested Posts

Nothing Found! Ready to publish your first post? Get started here.

Follow

Twitter 5K Linkedin 100 Tiktok 1

Popular

The White House View on Pharm-to-Table: ‘It’s Not the Solution in Itself’

Three New Drugs, Three Prices, Three Disclosure Approaches

A Big Study Found that Semaglutide Users Saw Increased Health Spending. Should We Be Surprised?

How MFN Raises the Possibility of a ‘Worst of Both Worlds’ Approach to International Drug Pricing

Boehringer Ingelheim’s Appeal to Overturn the IRA on Constitutional Grounds is Dismissed

Action On IRA Lawsuits: Appeals Court Rejects the U.S. Chamber Effort on Technical Grounds

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (2,382)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,535)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (1,354)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,311)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,308)
Archives
  • August 2025 (11)
  • July 2025 (21)
  • June 2025 (20)
  • May 2025 (21)
  • April 2025 (21)
  • March 2025 (20)
  • February 2025 (17)
  • January 2025 (21)
  • December 2024 (16)
  • November 2024 (17)
  • October 2024 (19)
  • September 2024 (19)
  • August 2024 (17)
  • July 2024 (18)
  • June 2024 (15)
  • May 2024 (17)
  • April 2024 (21)
  • March 2024 (18)
  • February 2024 (18)
  • January 2024 (18)
  • December 2023 (18)
  • November 2023 (16)
  • October 2023 (21)
  • September 2023 (6)
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe